{"nct_id":"NCT04129320","title":"Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and Neck","status":"WITHDRAWN","status_verified_date":"2022-02","start_date":"2019-10","start_date_type":"ESTIMATED","primary_completion_date":"2020-10","primary_completion_date_type":"ESTIMATED","completion_date":"2022-10","completion_date_type":"ESTIMATED","phases":["PHASE2","PHASE3"],"tickers":["MGNX"]}